Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis Patients

Clinical Epidemiology
Angelo KaraboyasBruce M Robinson

Abstract

Reproducibility of clinical and epidemiologic research is important to generalize findings and has increasingly been scrutinized. A recently published randomized trial, PIVOTAL, evaluated high vs low intravenous iron dosing strategies to manage anemia in hemodialysis patients in the UK. Our objective was to assess the reproducibility of the PIVOTAL trial findings using data from a well-established cohort study, the Dialysis Outcomes and Practice Patterns Study (DOPPS). To overcome the absence of randomization in the DOPPS, we applied the parametric g-formula, an extension of standardization to longitudinal data. We estimated the effect of a proactive high-dose vs reactive low-dose iron supplementation strategy on all-cause mortality (primary outcome), hemoglobin, two measures of iron concentration (ferritin and TSAT), and erythropoiesis-stimulating agent dose over 12 months of follow-up in 6325 DOPPS patients. Comparing high- vs low-iron dose strategies, the 1-year mortality risk difference was 0.020 (95% CI: 0.008, 0.031) and risk ratio was 1.20 (95% CI: 1.07, 1.33), compared with null 1-year findings in the PIVOTAL trial. Differences in secondary outcomes were directionally consistent but of lesser magnitude than in the PIVOT...Continue Reading

References

May 22, 2004·Journal of the American Society of Nephrology : JASN·Harold I FeldmanGerald Faich
Jul 22, 2005·Journal of the American Society of Nephrology : JASN·Kamyar Kalantar-ZadehDavid G Warnock
Jul 13, 2006·Kidney International. Supplement·D Coyne
Feb 24, 2009·Advances in Chronic Kidney Disease·Kamyar Kalantar-ZadehAllen R Nissenson
Apr 25, 2009·International Journal of Epidemiology·Sarah L TaubmanMiguel A Hernán
Feb 9, 2010·American Journal of Epidemiology·Daniel Westreich, Stephen R Cole
Mar 4, 2010·JAMA : the Journal of the American Medical Association·M Alan BrookhartWolfgang C Winkelmayer
Aug 27, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Jonathan BazeleyBruce M Robinson
Dec 5, 2012·Statistics in Medicine·R M DanielJ A C Sterne
Apr 6, 2013·American Journal of Epidemiology·Stephen R ColeAshley I Naimi
Sep 1, 2011·Statistics in Biosciences·Jessica G YoungMiguel A Hernán
Aug 21, 2014·Epidemiology·Alexander P KeilStephen R Cole
Oct 17, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Dana C MiskulinUNKNOWN Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Stu
Nov 5, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Navdeep TangriUNKNOWN DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators
Mar 20, 2016·American Journal of Epidemiology·Miguel A Hernán, James M Robins
Oct 5, 2017·The New England Journal of Medicine·Miguel A Hernán, James M Robins
Apr 24, 2018·Statistics in Medicine·Michael Schomaker, Christian Heumann
Jul 17, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Angelo KaraboyasBruce M Robinson
Oct 12, 2018·American Journal of Nephrology·Iain C MacdougallUNKNOWN on behalf of the PIVOTAL Trial investigators
Oct 27, 2018·The New England Journal of Medicine·Iain C MacdougallUNKNOWN PIVOTAL Investigators and Committees
Apr 17, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Xiaojuan LiM Alan Brookhart
May 8, 2019·American Journal of Epidemiology·Sara LodiUNKNOWN INSIGHT START Study Group and the HIV-CAUSAL Collaboration
Jun 12, 2019·Clinical Journal of the American Society of Nephrology : CJASN·David Collister, Navdeep Tangri
Oct 10, 2019·JAMA Network Open·Victoria L BartlettJoseph S Ross
Jan 10, 2017·Nature Human Behaviour·Marcus R MunafòJohn P A Ioannidis

❮ Previous
Next ❯

Software Mentioned

SAS
PIVOTAL

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.